HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Tilray Brands

As the coronavirus breakout was just beginning to be seen as a major threat to our health and to the economy back in March, it wasn’t clear what the implications might be to the cannabis industry, which was already struggling with a capital crunch that had intensified during the vaping crisis in.

Three Reasons To Be Bullish On Cannabis Stocks

Investors should take any growth projections in the industry with a grain of salt.

4 Times When Cannabis Companies Badly Missed Their Forecasts

There are a lot of negatives and risk to the company, but there is a lot of potential too.

Could HEXO Be a Millionaire-Maker Stock?

Since the middle of last year, marijuana stocks have taken a major beating. The best performing of the Canadian cultivation and retail stocks is down by more than a quarter, and the worst is down more than 85%.

Could These 6 Marijuana Stocks Recapture Much of Their Stock Losses?

The company is rolling out a set of medical marijuana products in a market far overseas.

Why HEXO Shares Got Higher on Thursday

U.S.-listed shares of Hexo Corp. HEXO, -0.98% HEXO, -1.05% shot up 18% in premarket trading Thursday, after the Canada-based cannabis company said it will start selling medical cannabis in Israel, marking the first time its medical cannabis products will be available outside of Canada.

Hexo's stock soars, after first medical cannabis sales outside of Canada

OTTAWA, July  09, 2020  (GLOBE NEWSWIRE) -- HEXO Corp (TSX: HEXO; NYSE: HEXO) (“HEXO” or the “Company”) is proud to announce that it has launched medical cannabis products in Israel through a 24-month agreement with leading Israeli medical cannabis company, Breath of Life International Ltd. (“BOL”).

HEXO launches medical cannabis products in Israel

Scotts Miracle-Gro

With more states in the US and Canada likely to legalize marijuana and calls for marijuana decriminalization growing louder, the cannabis industry is poised to bounce back in the second half.

Get Ready for a Green Rush in the Second Half: 3 Must Buys

OTTAWA, June  30, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the final closing of its previously announced early conversion option (the “Early Conversion Option”) in respect of $29.86 million aggregate principal amount of its outstanding $70 million aggregate principal amount of 8% unsecured convertible debentures maturing December 5, 2022 (the “Debentures”). Under the final closing, $6,265,000 aggregate principal amount of Debentures was converted into 7,831,250 units of the Company (the “Conversion Units”) at a price of $0.80 per Conversion Unit. Together with the $23,595,000 aggregate principal amount of Debentures converted into ‎29,493,750 Conversion Units in an initial closing on June 10, 2020, the Company has converted a total of $29,860,000 aggregate principal amount of Debentures into 37,325,000 Conversion Units under the Early Conversion Option.

HEXO Corp. Announces Final Closing of Early Conversion Option for Debentures

It's unlikely these pot stocks will be showing shareholders the green anytime soon.

3 Cannabis Stocks to Avoid Like the Plague for the Second Half of 2020

An analyst is more bullish about the Canadian marijuana stock.

Why HEXO Stock Jumped Today

Here's why investors are excited about this troubled cannabis company that is making a comeback.

Why Is Everyone Talking About HEXO Stock?

The first half of this year certainly had its ups and downs for cannabis stock owners. Here's what you can buy for a second-half recovery.

4 Marijuana Stocks to Buy Ahead of the Market Recovery

The company's coming off a third-quarter performance that wasn't all that impressive.

3 Reasons to Dump Shares of HEXO Today

Goodwill isn't the only cause for concern on marijuana companies' balance sheets.

Expect Big Asset Writedowns From Canadian Pot Stocks in the Coming Quarters

Green Thumb Industries Inc.

OrganiGram Holdings Inc.

Trulieve Cannabis Corp.

Amid recession and social unrest, the cannabis industry sees its moment.

Why more states could legalize cannabis in 2021

Zynerba Pharmaceuticals

The marijuana stocks plunged during the coronavirus sell-off. Should investors be taking a second look?

Is This a Buying Opportunity in the Marijuana Stocks?

Pot stock valuations have plummeted, and these CEOs could pay the price for this underperformance.

3 Cannabis Stock CEOs Who May Lose Their Jobs

This cannabis stock isn't worth the trouble, even with its shares trading for about $1 apiece.

2 Reasons to Stay Away From HEXO After Its Blowout Third Quarter

A new class-action lawsuit is a buzz kill for the two Canadian peers.

Why Marijuana Stocks HEXO and Organigram Holdings Got Trounced on Friday

Don't bother buying Hexo stock here. Instead, look for stronger cannabis stocks that have better balance sheets and bigger potential.

Hexo Stock Still Has a Major Cash Problem

After a string of bad news, HEXO’s third-quarter results came as a wee bit of a surprise.

2 Surprises in HEXO's Q3 Results: Is the Pot Stock Finally a Buy?

OTTAWA, June  17, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it completed the previously disclosed sale of its Niagara, Ontario facility for proceeds of approximately $10.25 million on June 15, 2020.

HEXO Corp. Announces the Sale of its Niagara Facility

Why HEXO Stock Is Tumbling Today

The U.S.-listed shares of Hexo Corp. HEXO, -10.16% sank 8.0% in premarket trading Wednesday, after the Canada-based consumer packaged goods cannabis company announced a C$34.5 million ($25.5 million) at-the-market stock offering program.

News for HEXO Corp Stock (HEXO)